Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to September 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $2.2B |
| Sales growthchange from the year before | +25.7% |
| Gross marginshare of sales left after the direct cost of what it sells | 18.8% |
| Operating marginshare of sales left after running the business | -5.1% |
| Net marginshare of sales kept as profit | -0.8% |
| Return on invested capitalprofit made on each $100 put into the business | -13.7% |
| Return on equityprofit vs. shareholders' accounting value | -2.6% |
| Change in share countnegative = the company is buying back its shares | +13.6% |
7 insiders sold $2.9M (19% under pre-arranged plans) on the open market.
| Kane CharlesDirector | Sold (plan)Aug 3 | 2,000 shat $43.21 · $86K |
| Krasnow ToddDirector | Sold (plan)Aug 3 | 2,000 shat $45.27 · $91K |
| Martins Izilda PChief Financial Officer | SoldJul 27 | 27,463 shat $40.80 · $1.1M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy